Reg­u­la­tors throw up an­oth­er hur­dle to Roche’s $4.3B Spark ac­qui­si­tion as ques­tions per­co­late over he­mo­phil­ia mar­ket dom­i­na­tion

Don’t look for Roche’s $4.3 bil­lion Spark $ONCE buy­out — an­nounced 7 months ago — to close any­time in the very near fu­ture.

The UK Com­pe­ti­tion and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.